Nunes Anne bought ANIK
March 11, 2024 · Form 4 insider transaction
Nunes Anne bought 3,295 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,295
Price
$0.00
Total value
N/A
InsiderNunes Anne
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 11, 2024
Filing dateMarch 12, 2024
Shares owned after10,245
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the first vesting installment of RSUs granted on March 9, 2023.; Reflects the corrected Amount of Shares Beneficially Owned under Table I, Column 2 as reported in Form 3/A filed by the Reporting Person on January 12, 2024.; Includes 414 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.